title: New approach for drug susceptibility testing: monitoring the stress response of mycobacteria.
abstract: Methods currently used for in vitro drug susceptibility testing are based on the assessment of bacterial growth-related processes. This reliance on cellular reproduction leads to prolonged incubation times, particularly for slowly growing organisms such as mycobacteria. A new rapid phenotypic method for the drug susceptibility testing of mycobacteria is described. The method is based on the detection of the physiological stress developed by susceptible mycobacterial cells in the presence of an antimicrobial compound. The induced stress was quantified by differential monitoring of the dielectric properties of the bacterial suspension, an easily measurable electronic property. The data presented here characterize the stress developed by Mycobacterium tuberculosis cells treated with rifampin (rifampicin), isoniazid, ethambutol, and pyrazinamide. Changes in the dielectric-based profiles of the drug-treated bacteria revealed the respective susceptibilities in near real time, and the susceptibilities were well correlated with conventional susceptibility test data.
authors.affiliation: BioSense Technologies, Inc., 4 Arrow Drive, Woburn, MA 01801, USA. rieder@biosensetech.com
authors.forename: Ronald J
authors.initials: RJ
authors.lastname: Rieder
authors.forename: Zhihui
authors.initials: Z
authors.lastname: Zhao
authors.forename: Boris
authors.initials: B
authors.lastname: Zavizion
mesh_terms: D017097:Electric Impedance; D008826:Microbial Sensitivity Tests / Q000379:methods*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000254:growth & development; D011718:Pyrazinamide / Q000494:pharmacology; D013312:Stress, Physiological
chemical_list: D011718:Pyrazinamide
references.citation: J Clin Microbiol. 2002 Jun;40(6):2238-9
references.pmid: 12037096
references.citation: J Clin Microbiol. 1986 Dec;24(6):976-81
references.pmid: 3097069
references.citation: J Med Microbiol. 2002 Jan;51(1):42-49
references.pmid: 11800471
references.citation: Crit Rev Microbiol. 2005;31(2):69-78
references.pmid: 15986832
references.citation: J Clin Microbiol. 2007 Jan;45(1):179-92
references.pmid: 17108078
references.citation: Antimicrob Agents Chemother. 1996 Aug;40(8):1768-74
references.pmid: 8843279
references.citation: Ann N Y Acad Sci. 2007 Oct;1113:105-13
references.pmid: 17483210
references.citation: N Engl J Med. 2007 Feb 15;356(7):656-9
references.pmid: 17301295
references.citation: J Clin Microbiol. 2007 Aug;45(8):2662-8
references.pmid: 17537932
references.citation: Microbiology (Reading). 2009 Apr;155(Pt 4):1093-1102
references.pmid: 19332811
references.citation: FEMS Microbiol Rev. 2007 Nov;31(6):637-56
references.pmid: 17883408
references.citation: BMC Public Health. 2008 Jan 14;8:15
references.pmid: 18194573
references.citation: Mini Rev Med Chem. 2007 Nov;7(11):1177-85
references.pmid: 18045221
references.citation: Ann N Y Acad Sci. 2007 Oct;1113:95-104
references.pmid: 17483204
references.citation: Lancet Infect Dis. 2009 Mar;9(3):153-61
references.pmid: 19246019
references.citation: Eur Respir J Suppl. 2002 Jul;36:87s-94s
references.pmid: 12168751
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17025-30
references.pmid: 12482953
references.citation: J Bacteriol. 2006 Nov;188(22):7988-91
references.pmid: 16980465
references.citation: Curr Opin Struct Biol. 2007 Dec;17(6):755-60
references.pmid: 17920859
references.citation: Antimicrob Agents Chemother. 1995 Oct;39(10):2235-8
references.pmid: 8619574
references.citation: Antimicrob Agents Chemother. 2007 Jun;51(6):2100-4
references.pmid: 17438054
references.citation: MMWR Recomm Rep. 2005 Apr 15;54(RR-6):1-12
references.pmid: 15829862
references.citation: J Clin Microbiol. 1996 Jan;34(1):84-6
references.pmid: 8748279
references.citation: Clin Infect Dis. 2002 Nov 1;35(9):1106-12
references.pmid: 12384845
references.citation: J Clin Microbiol. 2000 Oct;38(10):3686-8
references.pmid: 11015384